CrushSCI.com
208.7Average days
177.5Median days
27Fastest days
396Longest days
262025 publications

Paper Review Records

All Paper Review Records

18 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

174 days

Tebapivat: Pharmacokinetic Properties in Preclinical Species and Pharmacodynamic Responses Associated With Pyruvate Kinase Activation in Wild‐Type Mice

Authors
Chuck Locuson; Sebastien Ronseaux; Michael McVayShow moreShow less
Affiliations
1. Agios Pharmaceuticals, Inc. Cambridge Massachusetts USA; 2. Atavistik Bio Cambridge Massachusetts USAShow moreShow less
Source PDF DOI Publisher page
100 days

Development of a Biorelevant In Vitro Release System and Level A In Vitro‐In Vivo Correlation for Doxorubicin Hydrochloride Liposome Injection via Flow‐Through Cell Method

Authors
Xue‐ting Huang; Jing‐jing Liu; Xi‐yang Tang; Guo Yin; Yi Dai; Xiao‐wei WangShow moreShow less
Affiliations
1. College of Pharmacy and International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education Jinan University Guangzhou China; 2. Shenzhen Institute for Drug Control Shenzhen ChinaShow moreShow less
Source PDF DOI Publisher page
176 days

Prediction of Human Serum Concentration–Time Profiles of Golimumab and Ustekinumab Using Pharmacokinetic Data From Common Marmosets With Assessment of Anti‐Drug Antibodies

Authors
Ayaka Tajiri; Shogo Matsumoto; Nanami Furukawa; Kensuke Kagiyama; Hiroshi Ikeda; Kazumasa Fukasawa; Hiroki TakanoShow moreShow less
Affiliations
1. Drug Discovery Department R&D Division Meiji Seika Pharma Co. Ltd. Tokyo Japan; 2. Yaotsu Breeding Center CLEA Japan, Inc. Gifu Japan; 3. Tokyo Animal and Diet Department CLEA Japan, Inc. Tokyo JapanShow moreShow less
Source PDF DOI Publisher page
257 days

Optimized GFR Estimation Equations for Chinese Neonates and Children: Development of New Models and Comparison With Existing Ones

Authors
Hiotong Lam; Yahui Zhang; Zhe Hou; Jinfang Yuan; Zihan Lei; Haiyan Li; Xueting Yao; Tongyan Han; Dongyang LiuShow moreShow less
Affiliations
1. Department of Pediatrics Peking University Third Hospital Beijing China; 2. Drug Clinical Trial Center Peking University Third Hospital Beijing China; 3. Department of Pulmonary and Critical Care Medicine Peking University Third Hospital Beijing China; 4. Center of Clinical Medical Research, Institute of Medical Innovation and Research Peking University Third Hospital Beijing China; 5. Department of Cardiology Peking University Third Hospital Beijing ChinaShow moreShow less
Source PDF DOI Publisher page
344 days

Pharmacokinetic Assessment of Atazanavir and Favipiravir Following Echinacea Supplementation: A Controlled Herb–Drug Interaction Investigation

Authors
Siva Nageswara Rao Gajula; Jeevan Sai Kallam; Aarika Kanukolanu; Ganesh Korada; Lakshmi Vineela NallaShow moreShow less
Affiliations
1. Department of Pharmaceutical Analysis GITAM School of Pharmacy GITAM (Deemed to be University) Visakhapatnam Andhra Pradesh India; 2. Multidisciplinary Unit of Research on Translational Initiatives‐Sophisticated Analytical Instrumentation Facility (MURTI‐SAIF) GITAM (Deemed to be University) Visakhapatnam Andhra Pradesh India; 3. Department of Pharmacology GITAM School of Pharmacy GITAM (Deemed to be University) Visakhapatnam Andhra Pradesh IndiaShow moreShow less
Source PDF DOI Publisher page
382 days

Improvement of XZP8257 Dissolution Properties Through Amorphous and Mixed‐Phase Precipitate Formation in Biorelevant Media

Authors
Miao Zhang; Shudong Zhang; Bin Wu; Zhe Zhang; Qin Hu; Lin Wang; Dongyang LiuShow moreShow less
Affiliations
1. Drug Clinical Trial Center Peking University Third Hospital Beijing China; 2. Department of Pharmaceutical Sciences, School of Pharmacy, Bouve College of Health Sciences Northeastern University Boston Massachusetts USA; 3. NMPA Key Laboratory for Research and Evaluation of Generic Drugs Beijing Institute for Drug Control Beijing ChinaShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does BIOPHARMACEUTICS & DRUG DISPOSITION take to review a manuscript?

As of 2026-11-17, CrushSCI has 18 complete review records for BIOPHARMACEUTICS & DRUG DISPOSITION. The fastest paper went from submission to acceptance in 27 days (The Role of Nasal Drug Delivery in Migraine Management and Brain‐Targeted Therapy: Insights From Taiwan, received 2024-12-23, accepted 2025-01-19); the slowest took 396 days. The average is 208.7 days and the median is 177.5 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.